对于患有急性肝功能障碍的重症患者的血吸疗法:元分析和系统性审查
Caner Turan1,2, Csenge Erzsébet Szigetváry1,2, Tamás Kói2,3
1Department of Anesthesiology and Intensive Therapy, Semmelweis University, 1085 Budapest, Hungary.
Biomedicines
|January 23, 2024
概括
血液吸收疗法可以改善肝脏功能在严重病症患者急性肝脏功能障碍. 虽然通常是安全的,但需要更多高质量的研究来证实其临床益处和减少有毒代谢物的有效性.
科学领域:
- 关键护理医学 关键护理医学
- 肝病学 肝病学是一种肝病学.
- 腎臟醫學 腎臟醫學
背景情况:
- 危急病患者面临急性肝功能障碍的风险,作为多器官衰竭的一部分.
- 血液吸附的目的是清除血液中的毒素,可能防止进一步的器官损伤.
- 目前关于肝功能障碍的血液吸收疗效的证据有限.
研究的目的:
- 系统地审查并对肝功能障碍重症患者的血吸血疗法的临床结果进行元分析.
- 评估血吸血在改善肝功能和相关参数方面的安全性和有效性.
主要方法:
- 从2011年到2023年,在六个数据库 (PROSPERO注册:CRD42022286213) 进行系统的文献搜索.
- 包括30篇涉及335名肝脏功能障碍患者的论文.
- 分析了案例介绍,观察性研究和注册数据.
主要成果:
- 个别病例分析显示,阿斯巴酸氨酸酶和血管压缩剂需求显著减少 (p=0.03).
- 观察到总胆红素,氨酸转胺酶,C反应蛋白和肌素的降低趋势.
- 汇集的数据显示,总胆红素显著降低 (平均差异为-4.79 mg/dL,p=0.002).
结论:
- 血液吸附似乎对患有急性肝功能障碍的重症患者是安全的.
- 治疗表明治疗后肝功能改善的趋势.
- 高质量的证据至关重要,以确定血吸血的临床益处.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...


